unknown
Stage
1
Investors
About
Erebagen is a synthetic biology company that activates silent biosynthetic pathways in microbes to discover new enzymes and biocatalysts, enabling greener, more efficient chemical manufacturing processes.
Explore Erebagen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.